MedPath

MYLAN-OMEPRAZOLE

MYLAN-OMEPRAZOLE

Discontinued
DIN Number

02329433

Drug Class

Human

Market Date

Aug 4, 2009

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02329433
AIG Number0121643001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC01 OMEPRAZOLE
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

OMEPRAZOLEActive
Strength: 20 MG
Monograph: OMEPRAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.